Pharma TechAug 13, 2026
Repligen’s deal for BioLife Solutions indicates shift to manufacturing integration Â
Repligen’s $1.5bn purchase of BioLife Solutions adds CryoStor biopreservation to its bioprocessing portfolio, underscoring pharma’s shift toward integrated cell and gene therapy supply chains.
Read More





